Miravant Medical Technologies Stock Return On Asset
Miravant Medical Technologies fundamentals help investors to digest information that contributes to Miravant Medical's financial success or failures. It also enables traders to predict the movement of Miravant Stock. The fundamental analysis module provides a way to measure Miravant Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Miravant Medical stock.
Miravant |
Miravant Medical Technologies Company Return On Asset Analysis
Miravant Medical's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Miravant Medical Return On Asset | -1.1 |
Most of Miravant Medical's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Miravant Medical Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Miravant Medical Technologies has a Return On Asset of -1.0958. This is 87.48% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.
Miravant Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Miravant Medical's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Miravant Medical could also be used in its relative valuation, which is a method of valuing Miravant Medical by comparing valuation metrics of similar companies.Miravant Medical is currently under evaluation in return on asset category among its peers.
Miravant Fundamentals
Return On Asset | -1.1 | ||||
Current Valuation | 94.64 K | ||||
Price To Sales | 66.77 X | ||||
EBITDA | (13.33 M) | ||||
Net Income | (15.9 M) | ||||
Cash And Equivalents | 3.86 M | ||||
Cash Per Share | 0.10 X | ||||
Total Debt | 10.32 M | ||||
Current Ratio | 0.72 X | ||||
Book Value Per Share | (0.37) X | ||||
Cash Flow From Operations | (11.53 M) | ||||
Earnings Per Share | (0.41) X | ||||
Number Of Employees | 47 | ||||
Beta | -3.82 | ||||
Market Capitalization | 94.64 K | ||||
Total Asset | 7.51 M | ||||
Z Score | -3.3 | ||||
Annual Yield | 0.06 % | ||||
Net Asset | 7.51 M |
About Miravant Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Miravant Medical Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Miravant Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Miravant Medical Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Miravant Stock
If you are still planning to invest in Miravant Medical Tec check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Miravant Medical's history and understand the potential risks before investing.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |